112 related articles for article (PubMed ID: 3039693)
1. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
Ishizuka Y; Oka T; Kenjo T; Fujii A
Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
[TBL] [Abstract][Full Text] [Related]
2. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
3. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
Werling LL; Brown SR; Puttfarcken P; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
[TBL] [Abstract][Full Text] [Related]
4. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
Frances B; Moisand C; Meunier JC
Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
[TBL] [Abstract][Full Text] [Related]
5. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
Takayanagi I; Okumura K; Konno F; Koike K; Cho N; Hirobe M
Gen Pharmacol; 1985; 16(6):617-9. PubMed ID: 2867951
[TBL] [Abstract][Full Text] [Related]
8. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes.
Konkoy CS; Childers SR
Mol Pharmacol; 1989 Oct; 36(4):627-33. PubMed ID: 2572962
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of NaCl and guanyl-5'yl-imidodiphosphate (GppNHp) on [3H]naloxone binding to kappa-opioid receptors in guinea pig cerebellum.
Ishige K; Makimura M; Ito Y; Murakoshi Y
Biol Pharm Bull; 1993 Sep; 16(9):921-5. PubMed ID: 8268860
[TBL] [Abstract][Full Text] [Related]
11. Regulation of opioid antagonist and mu, kappa or delta agonist binding by guanine nucleotide and sodium.
Ishizuka Y; Oka T
Jpn J Pharmacol; 1984 Nov; 36(3):397-405. PubMed ID: 6097726
[TBL] [Abstract][Full Text] [Related]
12. Kappa-opiate binding to rat brain and guinea pig cerebellum: sensitivity towards ions and nucleotides.
Itzhak Y; Pasternak GW
Neurosci Lett; 1986 Feb; 64(1):81-4. PubMed ID: 3008039
[TBL] [Abstract][Full Text] [Related]
13. [Kappa-type opioid receptor in human placental membrane].
Ohta S; Niwa M; Nozaki M; Tsurumi K; Shimonaka H; Tanahashi T; Uematsu H; Yamamoto M; Fujimura H
Masui; 1989 Oct; 38(10):1293-300. PubMed ID: 2555580
[TBL] [Abstract][Full Text] [Related]
14. Kappa opiate binding sites in human placenta.
Porthé G; Valette A; Cros J
Biochem Biophys Res Commun; 1981 Jul; 101(1):1-6. PubMed ID: 6116490
[No Abstract] [Full Text] [Related]
15. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
Garzón J; Sánchez-Blázquez P; Lee NM
J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
[TBL] [Abstract][Full Text] [Related]
16. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors.
Hiller JM; Simon EJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):516-9. PubMed ID: 6249910
[TBL] [Abstract][Full Text] [Related]
17. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
Frances B; Puget A; Moisand C; Meunier JC
Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
[TBL] [Abstract][Full Text] [Related]
18. Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype.
Morre M; Bachy A; Gout B; Boigegrain R; Arnone M; Roncucci R
Life Sci; 1983; 33 Suppl 1():179-82. PubMed ID: 6141484
[TBL] [Abstract][Full Text] [Related]
19. Binding of dynorphin A and related peptides to kappa- and mu-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p.
Gairin JE; Botanch C; Cros J; Meunier JC
Eur J Pharmacol; 1989 Oct; 172(4-5):381-4. PubMed ID: 2573538
[TBL] [Abstract][Full Text] [Related]
20. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
Tam SW
Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
